1028 related articles for article (PubMed ID: 25362112)
1. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH
Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112
[TBL] [Abstract][Full Text] [Related]
2. Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1/2, p38 and NF-κB pathways.
Chen G; Pan SQ; Shen C; Pan SF; Zhang XM; He QY
Acta Pharmacol Sin; 2014 Apr; 35(4):463-75. PubMed ID: 24608673
[TBL] [Abstract][Full Text] [Related]
3. Antioxidant effects of hydrogen sulfide on left ventricular remodeling in smoking rats are mediated via PI3K/Akt-dependent activation of Nrf2.
Zhou X; Zhao L; Mao J; Huang J; Chen J
Toxicol Sci; 2015 Mar; 144(1):197-203. PubMed ID: 25516494
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotective effects of granulocyte colony-stimulating factor in angiotensin II-induced cardiac remodelling.
Jia N; Dong P; Huang Q; Jin W; Zhang J; Dai Q; Liu S
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):262-6. PubMed ID: 18785976
[TBL] [Abstract][Full Text] [Related]
5. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.
Li HL; Wang AB; Huang Y; Liu DP; Wei C; Williams GM; Zhang CN; Liu G; Liu YQ; Hao DL; Hui RT; Lin M; Liang CC
Free Radic Biol Med; 2005 Jan; 38(2):243-57. PubMed ID: 15607907
[TBL] [Abstract][Full Text] [Related]
6. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension.
Letavernier E; Perez J; Bellocq A; Mesnard L; de Castro Keller A; Haymann JP; Baud L
Circ Res; 2008 Mar; 102(6):720-8. PubMed ID: 18258859
[TBL] [Abstract][Full Text] [Related]
7. Protection by mTOR Inhibition on Zymosan-Induced Systemic Inflammatory Response and Oxidative/Nitrosative Stress: Contribution of mTOR/MEK1/ERK1/2/IKKβ/IκB-α/NF-κB Signalling Pathway.
Sahan-Firat S; Temiz-Resitoglu M; Guden DS; Kucukkavruk SP; Tunctan B; Sari AN; Kocak Z; Malik KU
Inflammation; 2018 Feb; 41(1):276-298. PubMed ID: 29110153
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease.
Zhang R; Zhang YY; Huang XR; Wu Y; Chung AC; Wu EX; Szalai AJ; Wong BC; Lau CP; Lan HY
Hypertension; 2010 Apr; 55(4):953-60. PubMed ID: 20157054
[TBL] [Abstract][Full Text] [Related]
9. Blockade of PAR-1 Signaling Attenuates Cardiac Hypertrophy and Fibrosis in Renin-Overexpressing Hypertensive Mice.
Yokono Y; Hanada K; Narita M; Tatara Y; Kawamura Y; Miura N; Kitayama K; Nakata M; Nozaka M; Kato T; Kudo N; Tsushima M; Toyama Y; Itoh K; Tomita H
J Am Heart Assoc; 2020 Jun; 9(12):e015616. PubMed ID: 32495720
[TBL] [Abstract][Full Text] [Related]
10. Administration of ubiquitin-activating enzyme UBA1 inhibitor PYR-41 attenuates angiotensin II-induced cardiac remodeling in mice.
Shu Q; Lai S; Wang XM; Zhang YL; Yang XL; Bi HL; Li HH
Biochem Biophys Res Commun; 2018 Oct; 505(1):317-324. PubMed ID: 30249396
[TBL] [Abstract][Full Text] [Related]
11. Tumor Necrosis Factor - Alpha Is Essential for Angiotensin II-Induced Ventricular Remodeling: Role for Oxidative Stress.
Sriramula S; Francis J
PLoS One; 2015; 10(9):e0138372. PubMed ID: 26378790
[TBL] [Abstract][Full Text] [Related]
12. PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats.
Bartha E; Solti I; Kereskai L; Lantos J; Plozer E; Magyar K; Szabados E; Kálai T; Hideg K; Halmosi R; Sumegi B; Toth K
Cardiovasc Res; 2009 Aug; 83(3):501-10. PubMed ID: 19443425
[TBL] [Abstract][Full Text] [Related]
13. Neohesperidin inhibits cardiac remodeling induced by Ang II in vivo and in vitro.
Zhang J; Fu X; Yang L; Wen H; Zhang L; Liu F; Lou Y; Yang Q; Ding Y
Biomed Pharmacother; 2020 Sep; 129():110364. PubMed ID: 32531678
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of 12/15 lipoxygenase by baicalein reduces myocardial ischemia/reperfusion injury via modulation of multiple signaling pathways.
Song L; Yang H; Wang HX; Tian C; Liu Y; Zeng XJ; Gao E; Kang YM; Du J; Li HH
Apoptosis; 2014 Apr; 19(4):567-80. PubMed ID: 24248985
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
[TBL] [Abstract][Full Text] [Related]
16. Effects of Xin-Ji-Er-Kang formula on 2K1C-induced hypertension and cardiovascular remodeling in rats.
Guo K; Lan CZ; Yu TT; Huang LL; Wang XH; Pan C; Gao S
J Ethnopharmacol; 2014 Sep; 155(2):1227-35. PubMed ID: 25063306
[TBL] [Abstract][Full Text] [Related]
17. Xanthohumol attenuates isoprenaline-induced cardiac hypertrophy and fibrosis through regulating PTEN/AKT/mTOR pathway.
Sun TL; Li WQ; Tong XL; Liu XY; Zhou WH
Eur J Pharmacol; 2021 Jan; 891():173690. PubMed ID: 33127362
[TBL] [Abstract][Full Text] [Related]
18. Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin II.
He Z; Zhang X; Chen C; Wen Z; Hoopes SL; Zeldin DC; Wang DW
Cardiovasc Res; 2015 Mar; 105(3):304-17. PubMed ID: 25618409
[TBL] [Abstract][Full Text] [Related]
19. Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice.
Suzuki K; Satoh K; Ikeda S; Sunamura S; Otsuki T; Satoh T; Kikuchi N; Omura J; Kurosawa R; Nogi M; Numano K; Sugimura K; Aoki T; Tatebe S; Miyata S; Mukherjee R; Spinale FG; Kadomatsu K; Shimokawa H
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):636-46. PubMed ID: 26916734
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling.
Izumiya Y; Kim S; Izumi Y; Yoshida K; Yoshiyama M; Matsuzawa A; Ichijo H; Iwao H
Circ Res; 2003 Oct; 93(9):874-83. PubMed ID: 14551246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
